Publications by authors named "Xavier Bertagna"

Claim this Profile
P
Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020.
Joël Coste, Laurence Mandereau-Bruno, Xavier Bertagna, Jean-Louis Wémeau

Eur Thyroid J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of potentially aggressive pituitary neuroendocrine tumors after radiotherapy: risk factors, management, and outcomes.
Fabio Bioletto, Caroline Bogeat, Maxime Barat, Nesrine Benanteur, Laurence Guignat, Xavier Bertagna

Eur J Endocrinol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Nelson's Syndrome to Corticotroph Tumor Progression Speed: An Update.
Laura Bessiène, Chiara Villa, Xavier Bertagna, Bertrand Baussart, Guillaume Assié

Exp Clin Endocrinol Diabetes· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology".
Patrick Nicolas, Xavier Bertagna

Eur J Drug Metab Pharmacokinet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular impairment in Primary Adrenal Insufficiency caused by Nicotinamide Nucleotide Transhydrogenase (NNT) deficiency - a case report: implication of oxidative stress and importance of fertility preservation.
Lucile Ferreux, Yasmine Boumerdassi, Emmanuel Dulioust, Xavier Bertagna, Florence Roucher-Boulez

Basic Clin Androl· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticotroph tumor progression speed after adrenalectomy.
Laura Bessiène, Sandrine Moutel, Marine Lataud, Anne Jouinot, Fidéline Bonnet-Serrano, Xavier Bertagna

Eur J Endocrinol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Rosario Pivonello, Maria Fleseriu, John Newell-Price, Xavier Bertagna, James Findling

Lancet Diabetes Endocrinol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pangenomic Classification of Pituitary Neuroendocrine Tumors.
Mario Neou, Chiara Villa, Roberta Armignacco, Anne Jouinot, Marie-Laure Raffin-Sanson, Xavier Bertagna

Cancer Cell· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.
Guillaume Assié, Anne Jouinot, Martin Fassnacht, Rossella Libé, Simon Garinet, Xavier Bertagna

JAMA Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Are the two formulas of Levothyrox bioequivalent?].
Joël Coste, Xavier Bertagna, Mahmoud Zureik, Patrick Nicolas, Paul Ramez

Rev Prat· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Levothyrox crisis].
Xavier Bertagna, Philippe Bouchard, Andre Grimaldi, Jean-Louis Wemeau, Jacques Young

Rev Prat· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".
Joël Coste, Xavier Bertagna, Mahmoud Zureik

Clin Pharmacokinet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Cushing's disease patients curable?
Xavier Bertagna

Ann Endocrinol (Paris)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Levothyrox : time of reason].
Xavier Bertagna, Philippe Bouchard, André Grimaldi, Jean-Louis Wémeau, Jacques Young

Rev Prat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.
Anne Jouinot, Guillaume Assie, Rossella Libe, Martin Fassnacht, Thomas Papathomas, Xavier Bertagna

J Clin Endocrinol Metab· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Chronic ACTH Excess on Human Adrenal Cortex.
Xavier Bertagna

Front Endocrinol (Lausanne)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.
Florence Roucher-Boulez, Delphine Mallet-Motak, Dinane Samara-Boustani, Houweyda Jilani, Asmahane Ladjouze, Xavier Bertagna

Eur J Endocrinol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adrenocortical carcinoma and pregnancy].
Marie-Laure Raffin-Sanson, Gwenaelle Abiven, Katrin Ritzel, Pauline de Corbière, Laure Cazabat, Xavier Bertagna

Ann Endocrinol (Paris)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic innovations in endocrine diseases - Part 1: New medical treatments for chronic excess of endogenous cortisol (Cushing's syndrome).
Xavier Bertagna

Presse Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.
Maria Fleseriu, Rosario Pivonello, Jacques Young, Amir H Hamrahian, Mark E Molitch, Xavier Bertagna

Pituitary· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma.
Pauline de Corbière, Katrin Ritzel, Laure Cazabat, Jacques Ropers, Matthias Schott, Xavier Bertagna

J Clin Endocrinol Metab· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Delphine Vezzosi, Florence Tenenbaum, Laure Cazabat, Frédérique Tissier, Marie Bienvenu, Xavier Bertagna

J Clin Endocrinol Metab· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas.
Claire Chambre, Emily McMurray, Camille Baudry, Marine Lataud, Laurence Guignat, Xavier Bertagna

Eur J Endocrinol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
Stéphanie Espiard, Ludivine Drougat, Rossella Libé, Guillaume Assié, Karine Perlemoine, Xavier Bertagna

J Clin Endocrinol Metab· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses.
Nathalie Launay, Stéphane Silvera, Florence Tenenbaum, Lionel Groussin, Frédérique Tissier, Xavier Bertagna

Int J Endocrinol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis